Schizophrenia
Item
patients diagnosed with schizophrenia
boolean
C0036341 (UMLS CUI [1])
Informed Consent
Item
patients who have given their own consent in writing to participate in the study
boolean
C0021430 (UMLS CUI [1])
Antipsychotic Agents Absent
Item
patients untreated with antipsychotics within 28 days before the screening test
boolean
C0040615 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Clinical Trial Specified Completed | Clinical Trial Continued | Evaluation | Clinical Trial Discontinued | Effectiveness Insufficient
Item
patients who have completed study jns007er-jpn-s31, or those who continued the study at least up to the evaluation at 2 weeks and subsequently discontinued the study due to insufficient efficacy
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0008976 (UMLS CUI [2,1])
C0549178 (UMLS CUI [2,2])
C1261322 (UMLS CUI [3])
C0008976 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
C1280519 (UMLS CUI [5,1])
C0231180 (UMLS CUI [5,2])
Participation Clinical Trial Specified | Ratio Therapeutic procedure Evaluation Percentage
Item
patients participating in study jns007er-jpn-s31 and whose ratio of treatment to the evaluation at 2 weeks is ≥75%
boolean
C0679823 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
C0456603 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1261322 (UMLS CUI [2,3])
C0439165 (UMLS CUI [2,4])
Mental disorders | Schizophrenia Excluded
Item
patients diagnosed with a mental disease other than schizophrenia
boolean
C0004936 (UMLS CUI [1])
C0036341 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Positive and negative syndrome scale
Item
a total panss score > 120 at baseline
boolean
C0451383 (UMLS CUI [1])
Substance Use Disorders
Item
substance-related disorders
boolean
C0038586 (UMLS CUI [1])
Parkinson Disease Complication
Item
parkinson's disease complications
boolean
C0030567 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
Convulsive disorder | Epilepsy
Item
current or a past history of convulsive disease such as epilepsy
boolean
C0234972 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
Cerebrovascular accident
Item
current or a past history of cerebrovascular accident
boolean
C0038454 (UMLS CUI [1])
Diabetes Mellitus
Item
diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Hepatic impairment | Renal Insufficiency
Item
significant hepatic or renal impairment
boolean
C0948807 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Cardiovascular Diseases
Item
significant cardiovascular disorders
boolean
C0007222 (UMLS CUI [1])
Hematology finding abnormal | Blood chemistry abnormal | Urine screening abnormal
Item
abnormal results of hematological examination, blood chemistry test and urinalysis at screening
boolean
C0475182 (UMLS CUI [1])
C0438258 (UMLS CUI [2])
C0438142 (UMLS CUI [3])
Pregnancy | Breast Feeding | Pregnancy, Planned | Pregnancy test positive
Item
pregnant women, breast-feeding mothers, and patients who wish pregnancy during the study period or those whose pregnancy test at screening was positive
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0240802 (UMLS CUI [4])
Medical contraindication Risperidone
Item
contraindications to risperidone products
boolean
C1301624 (UMLS CUI [1,1])
C0073393 (UMLS CUI [1,2])
Clinical Trial Specified Discontinued Due to Adverse event
Item
patients who discontinued study jns007er-jpn-s31 due to an adverse event not related to the underlying disease
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,3])
C0678226 (UMLS CUI [1,4])
C0877248 (UMLS CUI [1,5])
Study Subject Participation Status Inadequate
Item
patients judged inadequate by the investigator to participate in the study
boolean
C2348568 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])